The organisation must have documented procedures for evaluating complaints against adverse event reporting criteria, with any decision not to report made under the procedure and supported by a documented rationale, and must make effective arrangements for timely evaluation of quality problems in distributed product to decide whether to issue and implement an advisory notice, recording the risk-based rationale for both decisions to issue and decisions not to. The detailed jurisdiction rules are in Chapter 4. Clauses: ISO 13485:2016 4.2.1, 7.2.3, 8.2.3, 8.3.3; TG(MD)R Sch 3 Pt 1 cl 1.4(3)(c); RDC 665/2022 Art 120 VIII, RDC 67/2009, RDC 551/2021; CMDR 59 to 61.1 and 63 to 65.1; MO169 Arts 29, 55-3, 60-3; 21 CFR 803, 806, 820.10(b), 820.35(a).
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.